Key result
Hypercoagulability disorders can currently be correctly diagnosed in approximately 80% to 90% of patients, allowing for targeted treatment and testing of asymptomatic family members.
Population
Patients with hypercoagulability syndromes (inherited and/or acquired molecular defects)
Design
Review
Authors
Loading...
May guide selective thrombophilia testing; leaves open prospective validation of yield and family screening outcomes.
This review provides a logical approach for internists to identify and treat hypercoagulability syndromes, highlighting that 80% to 90% of these disorders can now be correctly diagnosed.
R. H. Thomas (2001) conducted a review in Hypercoagulability syndromes. Hypercoagulability disorders can currently be correctly diagnosed in approximately 80% to 90% of patients, allowing for targeted treatment and testing of asymptomatic family members.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: